Hôtel du Couvent
Sector: Hotel • Location: Nice, France
Source: Archinect
A hotel in Nice, France, restored from a 17th-century convent on 10,000 square meters of greenery near the seashore. The restoration used natural materials without pastiche, preserving the original essence and celebrating monastic life rituals with the restaurant in the old refectory and bakery and herbal pharmacy in original locations.
- Status
- Closed
- Sector
- Hotel
- Location
- Nice, France
- Updated
- 22 Jul 2026
- Source
- Archinect
ConstructChat
Ask ConstructChat about Hôtel du Couvent
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | Completed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | A hotel in Nice, France, restored from a 17th-century convent on 10,000 square meters of greenery near the seashore. The restoration used natural materials without pastiche, preserving the original essence and celebrating monastic life rituals with the restaurant in the old refectory and bakery and herbal pharmacy in original locations. |
Original sector | Built Environment |
Location
Country | France |
City | Nice |
Source
Source | Archinect |
URL |
More Details
Record type | Project |
Sector | Hotel |
Article published date | 2025-06-04 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hotel projects in France
- Mama Shelter Hotels
- Genzyme Biomanufacturing Plant
- AstraZeneca Symbicort Production Facility, Dunkirk
- Sanofi’s Evolutive Vaccine Facility (EVF), Neuville-sur-Saône
- Ferring Pharmaceuticals Biotechnology Centre, Saint-Prex, Switzerland
- Yposkesi’s Cell and Gene Therapy Facility, Corbeil-Essonnes, France
- Univercells’ Cell and Gene Therapy Manufacturing Facility, Jumet, Belgium
- Phase IIb/III Clinical Trial in ndGBM patients
